SMAD3 and neoplasm: In breast cancer, bFGF enhances the recruitment of bone mesenchymal stem cells (BMSCs) and their transdifferentiation into CAFs, potentially via the Erk1/2 and Smad3 pathways, leading to increased tumor cell proliferation and collagen production in the tumor microenvironment [47].